Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FABP4 | P15090 | 3/20 | 0.61 |
| ▸ | FABP5 | Q01469 | 3/20 | 0.61 |
| ▸ | FABP3 | P05413 | 1/20 | 0.61 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.54 |
| ▸ | HDAC6 | Q9UBN7 | 4/20 | 0.51 |
| ▸ | FNTA | P49354 | 2/20 | 0.45 |
| ▸ | FNTB | P49356 | 2/20 | 0.45 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.45 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.44 |
| ▸ | HPGD | P15428 | 1/20 | 0.44 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.44 |
| ▸ | HDAC1 | Q13547 | 3/20 | 0.44 |
| ▸ | MEN1 | O00255 | 1/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.44 |
| ▸ | BACE1 | P56817 | 2/20 | 0.43 |
| ▸ | LMNA | P02545 | 1/20 | 0.43 |
| ▸ | GAA | P10253 | 1/20 | 0.43 |
| ▸ | CNR2 | P34972 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1246435 | 0.77 | FABP4 (0.69) | FABP4FABP5FABP3KDM4EHDAC6 | |
| SCHEMBL150033 | 0.76 | FABP4 (1.00) | FABP4FABP5FABP3KDM4EHDAC6 | |
| SCHEMBL30549325 | 0.76 | FABP4 (1.00) | FABP4FABP5FABP3KDM4EHDAC6 | |
| SCHEMBL31093102 | 0.75 | FABP4 (0.56) | FABP4FABP5FABP3KDM4EHDAC6 | |
| SCHEMBL9768532 | 0.73 | CYP1A2 (0.70) | FABP4FABP5FABP3KDM4EHDAC6 | |
| SCHEMBL7990104 | 0.73 | MAOA (0.56) | KDM4EALDH1A1HPGDMEN1KMT2A | |
| SCHEMBL31093149 | 0.72 | KDM4E (0.56) | FABP4FABP5FABP3KDM4EHDAC6 | |
| SCHEMBL12110566 | 0.72 | FABP4 (0.62) | FABP4FABP5FABP3KDM4EHDAC6 | |
| SCHEMBL31093170 | 0.72 | SLC6A4 (0.69) | ALDH1A1KMT2A | |
| SCHEMBL31092925 | 0.72 | SLC6A4 (0.45) | ALDH1A1HPGDMEN1KMT2ALMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260035497-A1 | AMINE CONTAINING COPOLYMERS VIA EMULSION POLYMERIZATION AND METHODS OF USE THEREOF | INFINEUM INTERNATIONAL LIMITED (US) | 2026-02-05 | — | — | US | claimed |
| US-20260035493-A1 | AMINE CONTAINING COPOLYMERS VIA RADICAL POLYMERIZATION AND METHODS OF USE THEREOF | INFINEUM INTERNATIONAL LIMITED (US) | 2026-02-05 | — | — | US | claimed |
| US-20260028457-A1 | AMINE CONTAINING COPOLYMER EMULSION COMPOSITIONS AND METHODS OF MAKING AND USE THEREOF | INFINEUM INTERNATIONAL LIMITED (US) | 2026-01-29 | — | — | US | claimed |
| US-20250250379-A1 | AMINE CONTAINING POLYMER COMPOSITIONS AND USES THEREOF | INFINEUM INTERNATIONAL LIMITED (US) | 2025-08-07 | — | — | US | claimed |
| EP-4596661-A1 | AMINE CONTAINING POLYMER COMPOSITIONS AND USES THEREOF | Infineum International Limited (GB) | 2025-08-06 | — | — | EP | claimed |
| US-20240287009-A1 | AMINE-FUNCTIONAL MONOMERS AND METHODS OF MAKING SAME | INFINEUM INTERNATIONAL LIMITED (GB) | 2024-08-29 | — | — | US | claimed |
| EP-4410772-A2 | AMINE-FUNCTIONAL MONOMERS AND METHODS OF MAKING SAME | Infineum International Limited (GB) | 2024-08-07 | — | — | EP | claimed |
| CN-118440229-A | Amine functional monomers and methods of making the same | 英菲诺姆国际有限公司 | 2024-08-06 | — | — | CN | claimed |
| US-20260035497-A1 | AMINE CONTAINING COPOLYMERS VIA EMULSION POLYMERIZATION AND METHODS OF USE THEREOF | INFINEUM INTERNATIONAL LIMITED (US) | 2026-02-05 | — | — | US | disclosed |
| US-20260035495-A1 | FUNCTIONAL COPOLYMERS AND METHODS OF PREPARATION THEREOF | Kraton Corporation (US) | 2026-02-05 | — | — | US | disclosed |
| US-20260035493-A1 | AMINE CONTAINING COPOLYMERS VIA RADICAL POLYMERIZATION AND METHODS OF USE THEREOF | INFINEUM INTERNATIONAL LIMITED (US) | 2026-02-05 | — | — | US | disclosed |
| US-20260028457-A1 | AMINE CONTAINING COPOLYMER EMULSION COMPOSITIONS AND METHODS OF MAKING AND USE THEREOF | INFINEUM INTERNATIONAL LIMITED (US) | 2026-01-29 | — | — | US | disclosed |
| US-20250250379-A1 | AMINE CONTAINING POLYMER COMPOSITIONS AND USES THEREOF | INFINEUM INTERNATIONAL LIMITED (US) | 2025-08-07 | — | — | US | disclosed |
| EP-4596661-A1 | AMINE CONTAINING POLYMER COMPOSITIONS AND USES THEREOF | Infineum International Limited (GB) | 2025-08-06 | — | — | EP | disclosed |
| US-20240287009-A1 | AMINE-FUNCTIONAL MONOMERS AND METHODS OF MAKING SAME | INFINEUM INTERNATIONAL LIMITED (GB) | 2024-08-29 | — | — | US | disclosed |
| EP-4410772-A2 | AMINE-FUNCTIONAL MONOMERS AND METHODS OF MAKING SAME | Infineum International Limited (GB) | 2024-08-07 | — | — | EP | disclosed |
| CN-118440229-A | Amine functional monomers and methods of making the same | 英菲诺姆国际有限公司 | 2024-08-06 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260035495-A1 | FUNCTIONAL COPOLYMERS AND METHODS OF PREPARATION THEREOF | VCL, FGB, CDH1 | FABP4 3264/4885FABP5 3920/4885FABP3 4135/4885 |
| US-20260035493-A1 | AMINE CONTAINING COPOLYMERS VIA RADICAL POLYMERIZATION AND METHODS OF USE THEREOF | CBS, SELP, RAD51 | FABP4 4464/4885FABP5 4868/4885FABP3 4812/4885 |
| US-20240287009-A1 | AMINE-FUNCTIONAL MONOMERS AND METHODS OF MAKING SAME | AMD1, HNMT, MAT1A | FABP4 4374/4885FABP5 4684/4885FABP3 4805/4885 |
| US-20260035497-A1 | AMINE CONTAINING COPOLYMERS VIA EMULSION POLYMERIZATION AND METHODS OF USE THEREOF | DEGS1, SGMS1, PHOSPHO1 | FABP4 2430/4885FABP5 4282/4885FABP3 4069/4885 |
| US-20260028457-A1 | AMINE CONTAINING COPOLYMER EMULSION COMPOSITIONS AND METHODS OF MAKING AND USE THEREOF | DEGS1, PHOSPHO1, NAPEPLD | FABP4 2361/4885FABP5 3741/4885FABP3 3468/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.